PedAM
Pediatric Disease Annotations & Medicines
| Disease | prostate cancer |
| Phenotype | C0686619|lymph node metastases |
| Sentences | 19 |
| PubMedID- 23898991 | Background: the prognosis of prostate cancer patients with lymph node metastases so small they can only be visualized by new imaging techniques as mr lymphography (mrl) is unknown. |
| PubMedID- 23712209 | Advanced highly accurate imaging methods for the detection of lymph node metastases in patients with prostate cancer have been developed, such as pet, single photon emission computed tomography (spect), diffusion-weighted mri and magnetic resonance lymphography (mrl). |
| PubMedID- 20182691 | [pelvic lymphadenitis after total hip arthroplasty : mimicking of lymph node metastases in a patient with prostate cancer]. |
| PubMedID- 24407208 | Re: topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study. |
| PubMedID- 24757671 | In other studies [63–65], the authors used intravenous infusions of ferumoxtran-10 (2.6 mg of iron/kg of body weight) as contrast media and effectively detected the lymph node metastases in patients with prostate cancer. |
| PubMedID- 22007203 | lymph node metastases associated with prostate cancer (pca) has been shown to be a poor prognostic factor. |
| PubMedID- 25897334 | It has been demonstrated that 11c-acetate is better than 18f-fdg in detecting local recurrences and regional lymph node metastases of prostate cancer 25. prostate-specific membrane antigen (psma) is significantly overexpressed on the surface of prostate cancer cells 26. it has also been reported that psma pet/ct using a 68ga-labeled psma ligand can detect lesions characteristic of prostate cancer with improved contrast when compared to 18f-fluoromethylcholine pet/ct, especially at low psa levels 27. these results suggest that psma targeting imaging may be useful in detection of lymph node metastases of prostate cancer. |
| PubMedID- 25943443 | Background: the aim of this study is to assess the prognosis of prostate cancer (pca) with lymph node metastases (lnm) detected in pelvic lymph node dissection (plnd) after radical prostatectomy (rp) and adjuvant androgen deprivation therapy (adt) in a chinese population. |
| PubMedID- 21342722 | The superiority of (18)f-fdg pet-ct for demonstrating osteolytic bone metastases compared to bone scintigraphy was presented in a case of prostate cancer in a patient with bone and lymph node metastases. |
| PubMedID- 22577462 | Among compound mouse models, pten+/−/nkx3.1−/− mice developed fewer pins than nkx3.1-proficient pten+/− mice that, however, progressed to invasive prostate cancer with lymph node metastases beyond one year of age [14]. |
| PubMedID- 21144040 | Occult lymph node metastases in patients with prostate cancer have been identified by this technique prior to salvage radiation therapy [9]. |
| PubMedID- 23823804 | There is increasing knowledge of lymph node metastases in patients with prostate cancer. |
| PubMedID- 22516714 | Objectives: to evaluate the outcomes of radical prostatectomy (rp) and pelvic lymph node dissection (plnd) for clinically organ confined prostate cancer (cap) with regional lymph node metastases (pn1) treated in the era of prostate-specific antigen (psa) screening. |
| PubMedID- 24441584 | Long-term outcomes following radiation therapy for prostate cancer patients with lymph node metastases at diagnosis treated with and without surgery. |
| PubMedID- 23344023 | Reported that vegf-c mrna expression was significantly higher in prostate cancer patients with lymph node metastases than those without. |
| PubMedID- 23465520 | Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study. |
| PubMedID- 23627451 | Context: prostate cancer (pc) with lymph node metastases (ln(+)) is relatively rare, whereas it is relatively common in disease with a gleason score (gs) 8 to 10 and virtually never seen in pc with gs 6 or less. |
| PubMedID- 22417806 | Value of pet/ct and mr lymphography in treatment of prostate cancer patients with lymph node metastases. |
| PubMedID- 22654636 | This shows that targeting src family kinases may inhibit growth and lymph node metastases of prostate cancer. |
Page: 1